Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
- Resource Type
- Article
- Source
- The Lancet; March 2024, Vol. 403 Issue: 10429 p838-849, 12p
- Subject
- Language
- ISSN
- 01406736; 1474547X